sorafenib has been researched along with Pulmonary Veno Occlusive Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Kataoka, M; Satoh, T; Yanagisawa, R; Yoshino, H | 1 |
1 other study(ies) available for sorafenib and Pulmonary Veno Occlusive Disease
| Article | Year |
|---|---|
Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
Topics: Aged; Benzamides; Drug Therapy, Combination; Female; Hemodynamics; Humans; Imatinib Mesylate; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pulmonary Veno-Occlusive Disease; Pyrimidines; Sorafenib; Treatment Outcome | 2012 |